You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:
Business Description: NIB Holdings Limited (NHF) is a national provider of private health insurance, life insurance, travel insurance and related health care activities to more than 900,000 people nationwide. NHF's strategy is to provide innovative, low cost health insurance products.
Strategy Analysis: NHF's strategy is to shape the future of private healthcare funding in a way that increases participation, enhances health outcomes and creates enterprise value. NHF's core business of the provision of private health insurance has a strategy of growing market share through the provision of innovative, low cost health insurance products. Key business initiatives include: Aggressively pursuing growth in the national market for private health insurance and market share, especially within the under 40 segment and outside of NSW; retaining customers through great customer service, nib product design and looking to migrate customers through different products as they age or their life circumstances change; pursue enterprise value adding health fund mergers and acquisitions; actively pursue product innovation aimed at enhancing customer value proposition and increasing our role in the financing of private health care expenditure; modernise and enhance organisational capability, efficiency and performance.
NIB Holdings reported NPAT down 5% to $36.29m for the half-year ended 31 December 2012. Revenues from ordinary activities were $633.34m, up 11% from last year. Basic and Diluted EPS were 8.3 cents compared to 8.2 cents last year. Net operating cash flow was $5.02m compared to $34.86m last year. The interim dividend declared was 5.00 cents, compared with 4.25 cents last year. Based upon the first half underwriting result and the acquisition of the New Zealand business, the company has upgraded its FY13 pre-tax net underwriting profit guidance to $75.0m to $78.0m (previously $70.0m to $75.0m). Supporting this guidance range are some key assumptions, including nib nzed making an underwriting profit of $5.0m to $7.0m and group premium revenue of between $1.2bn and $1.3bn.
The Age 22/05/2013 |
A piece of broker research came out last week that described the budget as a sensible one but an almost suicidal one for a government four months out from an election. Instead of trying to buy votes, it seemed intent instead on putting as many noses out of joint as it possibly could.
The Age 22/05/2013 |
In last week's budget, the government missed what will probably be its last opportunity to make the superannuation system fairer and more sustainable. While the government made some tough decisions, such as reneging on promised tax cuts, one of the fastest-growing expenses is the tax concessions for superannuation.
The Age 22/05/2013 |
Last week's budget was a bit of aho-hum affair on many levels related to superannuation, because most of the changes to the system had been announced back in April. The transfer of the Baby Bonus into an extra (reduced) payment for families eligible for Family Tax Benefit Part A, has drawn the light fairly and squarely on the costs of bearing and raising children. The recent debate about the opposition's Paid Parental Scheme versus the government's less-generous scheme has added fuel to the fire.
IMPORTANT: This information has been prepared without taking into account your objectives, financial situation or needs and you should consider if the information is appropriate for you before making an investment decision. Neither InvestSMART Financial Services Pty Ltd nor any of its Related Companies make any recommendations as to the merits of any investment opportunity referred to in its emails or its related websites. Product disclosure statements for financial products offered through InvestSMART can be downloaded from this website or obtained by contacting 1300 880 160. You should consider the product disclosure statement before making a decision about the product. All indications of performance returns are historical and can not be relied upon as an indicator for future performance.